Suppr超能文献

过氧化物酶体酶的差异诱导与调控:过氧化物酶体增殖在识别某些非诱变致癌物中的预测价值。

Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.

作者信息

Nemali M R, Reddy M K, Usuda N, Reddy P G, Comeau L D, Rao M S, Reddy J K

机构信息

Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611.

出版信息

Toxicol Appl Pharmacol. 1989 Jan;97(1):72-87. doi: 10.1016/0041-008x(89)90056-2.

Abstract

Hypolipidemic drugs and certain plasticizers markedly increase the number of peroxisomes in liver parenchymal cells. Continued exposure to peroxisome proliferators has been shown to produce essentially similar pleiotropic responses leading eventually to the development of liver tumors in rats and mice. These agents are not mutagenic in short-term test systems and do not appear to interact with or damage DNA. Accordingly, the events leading to or associated with the induction of peroxisome proliferation have been postulated to play a role in the development of liver tumors. Recent evidence indicates that persistent peroxisome proliferation leads to the formation of 8-hydroxyguanosine in rat liver DNA, which supports the role for oxidative stress. The mRNAs of the three peroxisomal beta-oxidation genes are induced over 20-fold in the livers of rats treated with nafenopin, Wy-14643, BR-931, and other structurally diverse peroxisome proliferators. This increase in beta-oxidation mRNAs is evident within 30 min to 1 hr and was maximal 8 to 16 hr after the administration of a single dose of these agents by gavage. The peroxisomal catalase and urate oxidase mRNAs increase about 2-fold in the livers of rats treated chronically with peroxisome proliferators. These results indicate that peroxisome proliferators differentially regulate different peroxisomal enzymes. The tissue specificity of peroxisomal beta-oxidation gene regulation by xenobiotics supports the contention that the development of liver tumors following exposure to peroxisome proliferators correlates well with the inducibility of peroxisome proliferation and the beta-oxidation genes. Although these agents are known to exert mitogenic response in liver, it is unlikely that stimulation of DNA synthesis alone is responsible for tumor development. Cell proliferation may, however, play a secondary role. The morphological phenomenon of peroxisome proliferation should serve as a simple, sensitive, and valuable biological indicator for the identification of nongenotoxic or nonmutagenic chemicals that may be carcinogenic. An understanding of the cellular and molecular basis of peroxisome proliferation is a prerequisite for the evaluation of toxicological implications of this phenomenon.

摘要

降血脂药物和某些增塑剂可显著增加肝实质细胞中过氧化物酶体的数量。持续接触过氧化物酶体增殖剂已被证明会产生基本相似的多效性反应,最终导致大鼠和小鼠发生肝肿瘤。这些药物在短期测试系统中不具有致突变性,似乎也不会与DNA相互作用或损伤DNA。因此,有人推测导致或与过氧化物酶体增殖诱导相关的事件在肝肿瘤的发生发展中起作用。最近的证据表明,持续的过氧化物酶体增殖会导致大鼠肝脏DNA中形成8-羟基鸟苷,这支持了氧化应激的作用。在用氯贝丁酯、Wy-14643、BR-931和其他结构不同的过氧化物酶体增殖剂处理的大鼠肝脏中,三种过氧化物酶体β-氧化基因的mRNA被诱导增加20倍以上。β-氧化mRNA的这种增加在30分钟至1小时内很明显,在通过灌胃单次给药这些药物后8至16小时达到最大值。在用过氧化物酶体增殖剂长期处理的大鼠肝脏中,过氧化物酶体过氧化氢酶和尿酸氧化酶的mRNA增加约2倍。这些结果表明,过氧化物酶体增殖剂对不同的过氧化物酶体酶有不同的调节作用。外源性物质对过氧化物酶体β-氧化基因调节的组织特异性支持了这样的观点,即接触过氧化物酶体增殖剂后肝肿瘤的发生与过氧化物酶体增殖和β-氧化基因的诱导能力密切相关。尽管已知这些药物会在肝脏中引发有丝分裂反应,但仅DNA合成的刺激不太可能是肿瘤发生的原因。然而,细胞增殖可能起次要作用。过氧化物酶体增殖的形态学现象应作为一种简单、敏感且有价值的生物学指标,用于识别可能具有致癌性的非遗传毒性或非致突变性化学物质。了解过氧化物酶体增殖的细胞和分子基础是评估这一现象毒理学意义的先决条件。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验